OXACILLIN
Generic: OXACILLIN
Baxter Healthcare CorporationManufacturer
INTRAVENOUSRoute
OXACILLIN SODIUMActive Substance
1989-10-26Original Approval
OXACILLIN is FDA application NDA050640, sponsored by BAXTER HLTHCARE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
92 reports
2
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
68 reports
3
ACUTE KIDNEY INJURY
63 reports
4
PYREXIA
59 reports
5
RASH
55 reports
6
OFF LABEL USE
45 reports
7
DRUG INTERACTION
42 reports
8
TOXIC EPIDERMAL NECROLYSIS
42 reports
9
PNEUMONIA
41 reports
10
RENAL FAILURE
40 reports